Study on the correlation between the risk of thrombosis and bleeding after hip and knee replacement and the effect of anticoagulation

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100041689

Enrollment

Unknown

Registered

2021-01-01

Start date

2021-01-05

Completion date

Unknown

Last updated

2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip and knee replacement, deep vein thrombosis

Interventions

1:aspirin

2:Enoxaparin

3:Rivaroxaban

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing femoral head replacement, total hip replacement, total knee replacement, and unicompartment knee replacement

Exclusion criteria

Exclusion criteria: Patients who cannot undergo surgery due to surgical contraindications or personal reasons will be excluded.

Design outcomes

Primary

Measure	Time frame
Thrombotic event;Bleeding event;Drainage;	—

Secondary

Measure	Time frame
Skin ecchymosis area;Serum albumin, etc.;	—

Countries

China

Contacts

Public ContactLu Ning

The Second Affiliated Hospital of Kunming Medical University

luningwei2@163.com+86 13888574273

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026